Search

Search Results

• HOUSEHOLDS’ FOOD CONSUMPTION BEHAVIOUR DURING COVID-19 PANDEMIC: EVIDENCE FROM RURAL HOUSEHOLDS IN SOUTH AFRICA

  Hilda Lefophane

  Felicity Ntombikayiso Mkasi

  Mapula Hildah Lefophane

  Views:

  129

  The food consumption behaviour of households has been affected by the lockdown restrictions that were implemented to reduce the COVID-19 infection rate. This study was aimed at analysing the food consumption behaviour of rural households during the COVID-19 pandemic in South Africa. To achieve this, a simple random technique was used to collect data from 120 in Merry Pebble (MP) Stream Village. Thereafter, an Ordered Probit Model was used to examine the extent to which households have increased, decreased or maintained the same quantity of food consumed during COVID-19. The results indicated that 46.7% of the rural households had consumed less food during COVID-19 pandemic, 32.5% consumed about the same amount of food, and 20.8% consumed more food. The variables that contributed towards a decrease in food consumption are employment status, household size, loss of income, and social relief grants. On the contrary, bulk buying and food parcels had stabilised food consumption, while the number of employed people in a household and food bought from restaurants contributed towards an increase in food consumption during COVID-19 pandemic. With regard to consumption behaviour per food item, fresh produce, meat, snacks and fast food were consumed less during COVID-19, while there was a constant consumption in dairy products, and an increase in consumption of canned food, frozen food, prepared food, grains and water. The study recommends that the government should continue with the economic and social relief programmes that were created during COVID-19, as they play an important role in increasing and stabilising food consumption by rural households.

• NEW METHODS FOR STRUCTURAL DEVELOPMENT CAUSED BY OPEN INNOVATION IN RED BIOTECHNOLOGY

  Balázs Kiss

  Dávid Domonkos

  János Felföldi

  Views:

  140

  Red (pharmaceutical) biotechnology is currently one of the most innovative industries. A good example of this is the fight to develop a vaccine against the COVID-19 pandemic, or even the incredible dynamism of the development of anti-cancer drugs.Innovations always carry uncertainty within them - the authors of this article see and experience this every day during their managerial work related to R&D in the biotechnology sector. Decisions often have to be made on uncertain grounds, with incomplete information. Mapping all these anomalies and their root causes is also necessary according to what has been experienced in various organizations, but at the same time it is a very interesting and challenging task. One of the possible means of sharing and reducing the risk is the so-called Open innovation, which required innovations in the fields of technical, industrial rights protection, privacy protection, but also cooperation platforms.All this required a new organizational and structural operation from the actors. This means that technological innovation attracts and results in project innovations. We assume that organizational development and structural innovations were also achieved through these transfers. We are trying to validate this hypothesis with the help of interviews with professionals.Our thesis: the challenges arising from the special innovation of red biotech also caused and necessitated the innovation of organizational structures and the development of its organizational and structural functioning, to which open innovation gave outstanding help.